Effect of Treatment with Oral Calcitriol on Calcium Metabolism and Fasting Serum 25(OH)- or 1,25(OH)2-Vitamin D Level in Japanese Postmenopausal Women

Endocrine Journal

Volumn 50, Issue 6, 2003, Pages 681-687

  Tsukamoto, Yusuke ^a   Watanabe, Tatsuhiko ^b   Nakagami, Tetsuo ^b   Morishita, Kaoru ^b  

^a Kasukabe Shuwa Hospital   (Japan)

^b Morishita Memorial Hospital   (Japan)

Author keywords

25 Hydroxyvitamin D; Bone mineral density; Calcitriol; Osteoporosis; Postmenopausal

Indexed keywords

25 HYDROXYVITAMIN D; CALCITRIOL;

ADULT; AGED; ARTICLE; CALCIUM ABSORPTION; CALCIUM BLOOD LEVEL; CALCIUM EXCRETION; CALCIUM METABOLISM; CLINICAL ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DRUG EFFECT; HUMAN; JAPAN; OSTEOLYSIS; POSTMENOPAUSE; VITAMIN BLOOD LEVEL;

ADMINISTRATION, ORAL; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BONE DENSITY; BONE RESORPTION; CALCITRIOL; CALCIUM; CALCIUM CHANNEL AGONISTS; FASTING; FEMALE; HUMANS; MIDDLE AGED; NITRATES; NITRITES; POSTMENOPAUSE; VITAMIN D;

EID: 0942276914     PISSN: 09188959     EISSN: None     Source Type: Journal    
DOI: 10.1507/endocrj.50.681     Document Type: Article

References (15)

1. Shikari M, Kushida K, Yamazaki K, Nagai T, Inoue T, Orimo H (1996) Effects of 2 years' treatment of osteoporosis with 1 alpha-hydroxy vitamin D3 on bone mineral density and incidence of fracture: a placebo-controlled, double-blind prospective study. Endocr J 43: 211-220.
2. Nakamura K, Nashimoto M, Hori Y, Yamamoto M (2000) Serum 25-hydroxyvitamin D concentrations and related dietary factors in peri- and postmenopausal Japanese women. Am J Clin Nutr 71: 1161-1165.
3. Need AG, Morris HA, Horowitz M, Nordin BE (1997) The response to calcitriol therapy in postmenopausal osteoporotic women is a function of initial calcium absorptive status. Calcif Tissue Int 61: 6-9.
4. Holzherr ML, Retallack RW, Gutteridge DH, Price RI, Faulkner DL, Wilson SG, Will RK, Stewart GO, Stuckey BG, Prince RL, Criddle RA, Kent GN, Bhagat CI, Dhaliwal SS, Jamrozik K (2000) Calcium absorption in postmenopausal osteoporosis: benefit of HRT plus calcitriol, but not HRT alone, in both malabsorbers and normal absorbers. Osteoporosis Int 11: 43-51.
5. Riggs BL, Nelson KI (1985) Effect of long term treatment with calcitriol on calcium absorption and mineral metabolism in postmenopausal osteoporosis. J Clin Endocrinol Metab 61: 457-461.
6. Aloia JF, Vaswani A, Yeh JK, Ellis K, Yasumura S, Cohn SH (1988) Calcitriol in the treatment of post-menopausal osteoporosis. Am J Med 84: 401-408.
7. Kikuchi R, Uemura T, Gorai I, Ohno S, Minaguchi H (1999) Early and late postmenopausal bone loss is associated with BsmI vitamin D receptor gene polymorphism in Japanese women. Calcif Tissue Int 64: 102-106.
8. Nakamura T (1997) The importance of genetic and nutritional factors in responses to vitamin D and its analogs in osteoporotic patients. Calcif Tissue Int 60: 119-123.
9. Gallagher JC (1990) Metabolic effects of synthetic calcitriol (Rocaltrol) in the treatment of postmenopausal osteoporosis. Metab Clin Exp 39 (4 Suppl 1): 27-29.
10. Ott SM, Chesnut CH, 3rd (1989) Calcitriol treatment is not effective in postmenopausal osteoporosis. Ann Intern Med 110: 267-274.
11. Tilyard MW, Spears GF, Thomson J, Dovey S (1992) Treatment of postmenopausal osteoporosis with calcitriol or calcium. N Engl J Med 326: 357-362.
12. Falch JA, Odegaard OR, Finnanger AM, Matheson I (1987) Postmenopausal osteoporosis: no effect of three years treatment with 1,25-dihydroxycholecalciferol. Acta Med Scand 221: 199-204.
13. Costa L, Demers LM, Gouveia-Oliviera A, Schaller J, Costa EB, de Moura MC (2002) Prospective evaluation of the peptide-bound collagen type I cross-links N-telopeptide and C-telopeptide in predicting bone metastases status. J Clin Oncol 20: 850-856.
14. Lips P, Duong T, Oleksik A, Black D, Cummings S, Cox D, Nickelsen T (2001) A global study of vitamin D status and parathyroid function in postmenopausal women with osteoporosis: baseline data from the multiple outcomes of raloxifene evaluation clinical trial. J Clin Endocrinol Metab 86: 1212-1221.
15. 3 receptors in peripheral blood mononuclear cells from patients with postmenopausal osteoporosis. Bone Miner 23: 207-212.